May Daher
Impact in
- Immunology top 0.5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Oncology top 0.5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 41
- Immune Cell Function and Interaction 39
- T-cell and B-cell Immunology 16
- Oncology 44
- CAR-T cell therapy research 35
- Co-authors
- Katayoun Rezvani (27 shared papers)Rafet Başar (12 shared papers)Hind Rafei (4 shared papers)Luciana Melo Garcia (1 shared paper)Ye Li (2 shared papers)Rohtesh S. Mehta (4 shared papers)Nils G. Walter (3 shared papers)Ken Chen (4 shared papers)
- Journals
- Blood (12 papers)Frontiers in Immunology (6 papers)Blood Advances (5 papers)Bone Marrow Transplantation (3 papers)Cancer Cell (3 papers)
- Partner nations
- United StatesCanadaIsrael
In The Last Decade
May Daher
78 papers receiving 5.2k citations
May Daher's Hit Papers
Peers
Comparison fields: 5 of 102
- Immunology 3.0k
- Oncology 3.3k
- Hematology 477
- Genetics 314
- Genetics 475
Countries citing papers authored by May Daher
This map shows the geographic impact of May Daher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by May Daher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites May Daher more than expected).
Fields of papers citing papers by May Daher
This network shows the impact of papers produced by May Daher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by May Daher. The network helps show where May Daher may publish in the future.
Co-authors
The 25 scholars most cited alongside May Daher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors Hit paper breakdown → | 2020 | 1743 |
| 2 | Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial Hit paper breakdown → | 2024 | 357 |
| 3 | Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity Hit paper breakdown → | 2022 | 273 |
| 4 | 2020 | 246 | |
| 5 | 2021 | 214 | |
| 6 | 2018 | 186 | |
| 7 | 2020 | 181 | |
| 8 | 2022 | 145 | |
| 9 | 2021 | 126 | |
| 10 | 2020 | 115 | |
| 11 | 2017 | 107 | |
| 12 | 2020 | 99 | |
| 13 | 2021 | 98 | |
| 14 | 2023 | 87 | |
| 15 | 2016 | 85 | |
| 16 | 2023 | 73 | |
| 17 | 2018 | 68 | |
| 18 | 2023 | 68 | |
| 19 | 2021 | 55 | |
| 20 | 2024 | 54 |
About May Daher
May Daher is a scholar working on Immunology, Oncology, Hematology, Genetics and Molecular Biology, having authored 85 papers that have together received 5.3k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (39 papers), CAR-T cell therapy research (35 papers), Hematopoietic Stem Cell Transplantation (17 papers), T-cell and B-cell Immunology (16 papers), Acute Myeloid Leukemia Research (10 papers), Chronic Lymphocytic Leukemia Research (7 papers), RNA modifications and cancer (5 papers) and Cytomegalovirus and herpesvirus research (5 papers). The work is most often cited by research in Immunology (3.0k citations), Oncology (3.3k citations), Hematology (477 citations), Genetics (314 citations) and Genetics (475 citations). May Daher has collaborated with scholars based in United States, Canada and Israel. Frequent co-authors include Katayoun Rezvani, Rafet Başar, Hind Rafei, Luciana Melo Garcia, Ye Li, Rohtesh S. Mehta, Nils G. Walter, Ken Chen, Li Li and Vakul Mohanty. Their work appears in journals such as Blood, Frontiers in Immunology, Blood Advances, Bone Marrow Transplantation and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.